ISPOR’s COMMITMENT TO GLOBAL INCLUSIVITY AND SCIENTIFIC EXCELLENCE

Published Mar 2, 2017
ANNOUNCEMENT

Princeton, NJ—March 2, 2017—“Science has no geographic boundaries,” said Nancy S. Berg, CEO and Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). “Scientific research and development is the basis for the rapid globalization of the ISPOR organization and its ongoing and strategic commitment to diverse stakeholder engagement. Scientific excellence and global inclusivity are key components of our organizational values, and of the global enterprise that our Society continues to reflect, encouraging and stimulating a culture of diverse scientific exchange.”

Berg posted these remarks following discussions on the impact of changing political landscapes, including possible travel restrictions as the Society prepares to host its major international meetings on health economics and outcomes research (HEOR) in countries in Asia, Europe, Latin America, and North America. As a scientific and educational society, ISPOR does not take positions on political issues; however, the Society strongly supports open scientific exchange within the global HEOR community, and views efforts to restrict such exchanges as impediments to its mission. ISPOR represents and serves a diverse global, multi-stakeholder audience of more than 20,000 individual and chapter members from 114 countries. The Society’s two MEDLINE®-indexed journals, Value in Health and Value in Health Regional Issues, publish studies from authors who span the globe. In addition, the members who serve in leadership roles for the Society, including the Board of Directors, editorial boards, conference chairs and committees, councils, roundtables, regional consortia and networks, chapters, task forces, and special interest groups represent perspectives from virtually every corner of the world. To foster this level of diversity and inclusion, ISPOR has established a number of initiatives that encourage and facilitate participation, including conference travel grants for attendees outside of North America and Western Europe, scientific awards that recognize researchers and authors worldwide, and membership fee waivers for individuals in low-income countries. It is through such initiatives and the ongoing support of its global network of consortia, networks, and chapters that ISPOR achieves its mission of promoting health economics and outcomes research excellence to improve decision making for health globally.

###

 

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×